Top Markets
Coin of the day
IPROMOMED IPROMOMED

IPROMOMED

PRMD
Rank in Stocks #9277
Operating out of Russia, iPROMOMED functions as a pharmaceutical and... Operating out of Russia, iPROMOMED functions as a pharmaceutical and biotechnology enterprise dedicated to the research, production, and commercialization of both traditional prescription medications and cutting-edge therapeutic solutions.
Share Price
$4.93
Last synced: 2026-08-28
Market Cap
$1.05B
Change (1 day)
1.36%
Change (1 year)
-9.02%
Country
RU
Trade IPROMOMED (PRMD)

Category

Revenue for IPROMOMED (PRMD)
Revenue in Aug 2026 TTM: 0
According to IPROMOMED latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for IPROMOMED from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors